Refractory mucosal candidiasis in patients with human immunodeficiency virus infection

Keyphrases

• Human Immunodeficiency Virus Infection 100%
• Candida Infection 100%
• Mucosal Candidiasis 100%
• Candidiasis 100%
• Human Immunodeficiency Virus Type 1 (HIV-1) 50%
• Itraconazole 50%
• Amphotericin B 50%
• Fluconazole 50%
• Antifungal Agents 50%
• Clinical Laboratory 50%
• Orally Administered 50%
• Oropharyngeal 50%
• Laboratory Standards 50%
• Failure to Respond 50%
• Difficult to Manage 50%
• Systematic Therapy 50%
• National Committee 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Human Immunodeficiency Virus Infection 100%
• Mucocutaneous Candidiasis 100%
• Candidiasis 66%
• Amphotericin B 33%
• Itraconazole 33%
• Fluconazole 33%
• Human Immunodeficiency Virus 1 33%
• Antifungal Agent 33%
• Diseases 33%

Immunology and Microbiology

• Human Immunodeficiency Virus Infection 100%
• Infection 100%
• Human Immunodeficiency Virus 1 33%
• In Vitro 33%
• Susceptibility 33%